Matrixyl and Argireline are both popular cosmetic peptides, but they work on different mechanisms and are often used together. Matrixyl (a palmitoyl "matrikine" peptide) signals the skin to build collagen for firmness; Argireline (an acetyl hexapeptide) targets the SNARE complex to soften expression lines. Both are topical and have modest, gradual effects.
At a glance
| Matrixyl | Argireline | |
|---|---|---|
| Type | Palmitoyl pentapeptide (matrikine) | Acetyl hexapeptide (SNARE-targeting) |
| Targets | Collagen production, firmness | Expression/movement lines |
| Best for | Overall texture, fine lines, firmness | Lines from facial movement |
| Regulation | Cosmetic ingredient | Cosmetic ingredient |
| Effect size | Modest, gradual | Modest, gradual |
| Route | Topical | Topical |
The bottom line
Bottom line: Complementary, not competing. Matrixyl works on collagen and overall skin quality; Argireline targets the lines caused by repeated facial movement. They're frequently combined in serums for that reason. Both are cosmetics with modest, cumulative effects — not drugs.
Frequently asked questions
What's the difference between Matrixyl and Argireline?
Matrixyl is a matrikine peptide that signals the skin to produce collagen for firmness, while Argireline is a SNARE-targeting peptide that softens expression lines. They address different signs of aging and are often used together.
Can you use Matrixyl and Argireline together?
Yes — they target different mechanisms (collagen support vs expression lines), so they're commonly combined in skincare. Both are cosmetics with modest, gradual effects.
Are these as effective as retinoids?
Cosmetic peptides like these have supportive but modest evidence and develop gradually. They are not drugs and are not a replacement for medical treatments such as retinoids.
References
Combined peer-reviewed sources from both peptide guides. Inclusion is not endorsement.
- Robinson LR, Fitzgerald NC, Doughty DG, et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. 2005. Peer-reviewed study
- Choi YL, Park EJ, Kim E, Na DH, Shin YH. Dermal stability and in vitro skin permeation of collagen pentapeptides (KTTKS and palmitoyl-KTTKS). Biomol Ther (Seoul). 2014. Peer-reviewed study
- Gomes A, Bessa LJ, Fernandes I, et al. Boosting Cosmeceutical Peptides: Coupling Imidazolium-Based Ionic Liquids to Pentapeptide-4 Originates New Leads with Antimicrobial and Collagenesis-Inducing Activities. Microbiol Spectr. 2022. Peer-reviewed study
- Kachooeian M, Mousivand Z, Sharifikolouei E, et al. Matrixyl Patch vs Matrixyl Cream: A Comparative In Vivo Investigation of Matrixyl (MTI) Effect on Wound Healing. ACS Omega. 2022. Peer-reviewed study
- Blanes-Mira C, Clemente J, Jodas G, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci. 2002. Peer-reviewed study
- Lim SH, Sun Y, Madanagopal TT, et al. Enhanced Skin Permeation of Anti-wrinkle Peptides via Molecular Modification. Sci Rep. 2018. Peer-reviewed study
- Velazco de Maldonado GJ, Suárez-Vega DV, Miller-Kobisher B, et al. Polydioxanone Bioactive Sutures-Acetyl Hexapeptide-8 (Argireline): An Intelligent System for Controlled Release in Facial Harmonization. J Cutan Aesthet Surg. 2023. Peer-reviewed study
- Wang Y, Wang M, Xiao S, et al. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol. 2013. Peer-reviewed study
- Chen CF, Liu J, Wang SS, et al. Mycobacterium abscessus infection after facial injection of argireline: A case report. World J Clin Cases. 2021. Peer-reviewed study
- Kluczyk A, Ludwiczak J, Modzel M, et al. Argireline: Needle-Free Botox as Analytical Challenge. Chem Biodivers. 2021. Peer-reviewed study